{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:14:12Z","timestamp":1790784852734,"version":"4.1.0"},"reference-count":185,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T00:00:00Z","timestamp":1665360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010751","name":"Fondo Nacional de Desarrollo Cient\u00edfico, Tecnol\u00f3gico y de Innovaci\u00f3n Tecnol\u00f3gica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010751","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010751","name":"Fondo Nacional de Desarrollo Cient\u00edfico, Tecnol\u00f3gico y de Innovaci\u00f3n Tecnol\u00f3gica","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010751","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Non-alcoholic fatty liver disease (NAFLD) is a complex and heterogeneous disorder considered a liver-damaging manifestation of metabolic syndrome. Its prevalence has increased in the last decades due to modern-day lifestyle factors associated with overweight and obesity, making it a relevant public health problem worldwide. The clinical progression of NAFLD is associated with advanced forms of liver injury such as fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). As such, diverse pharmacological strategies have been implemented over the last few years, principally focused on metabolic pathways involved in NAFLD progression. However, a variable response rate has been observed in NAFLD patients, which is explained by the interindividual heterogeneity of susceptibility to liver damage. In this scenario, it is necessary to search for different therapeutic approaches. It is worth noting that chronic low-grade inflammation constitutes a central mechanism in the pathogenesis and progression of NAFLD, associated with abnormal composition of the intestinal microbiota, increased lymphocyte activation in the intestine and immune effector mechanisms in liver. This review aims to discuss the current knowledge about the role of the immune response in NAFLD development. We have focused mainly on the impact of altered gut-liver-microbiota axis communication on immune cell activation in the intestinal mucosa and the role of subsequent lymphocyte homing to the liver in NAFLD development. We further discuss novel clinical trials that addressed the control of the liver and intestinal immune response to complement current NAFLD therapies.<\/jats:p>","DOI":"10.3389\/fimmu.2022.954869","type":"journal-article","created":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T10:30:22Z","timestamp":1665397822000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":35,"title":["The immune response as a therapeutic target in non-alcoholic fatty liver disease"],"prefix":"10.3389","volume":"13","author":[{"given":"Nicol\u00e1s","family":"Ortiz-L\u00f3pez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catalina","family":"Fuenzalida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Soledad","family":"Dufeu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Araceli","family":"Pinto-Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro","family":"Escobar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Poniachik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Pablo","family":"Roblero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda","family":"Valenzuela-P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroll J.","family":"Beltr\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1002\/cld.1045","article-title":"Nonalcoholic fatty liver disease and recent guideline updates","volume":"17","author":"Ando","year":"2021","journal-title":"Clin Liver Dis"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.15386\/cjmed-993","article-title":"Non-alcoholic fatty liver disease: An update on diagnosis","volume":"91","author":"Dumitrascu","year":"2018","journal-title":"Clujul Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1097\/cm9.0000000000002277","article-title":"Estimating global prevalence, incidence, and outcomes of non-alcoholic fatty liver disease from 2000 to 2021: Systematic review and meta-analysis","volume":"135","author":"Liu","year":"2022","journal-title":"Chin Med J (Engl)"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2019-036663","article-title":"Prevalence trends in non-alcoholic fatty liver disease at the global, regional and national levels, 1990-2017: A population-based observational study","volume":"10","author":"Ge","year":"2020","journal-title":"BMJ Open"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1080\/00365513.2019.1700428","article-title":"Metabolic syndrome but not genetic polymorphisms known to induce nafld predicts increased total mortality in subjects with nafld (Opera study)","volume":"80","author":"K\u00e4r\u00e4j\u00e4m\u00e4ki","year":"2020","journal-title":"Scand J Clin Lab Invest"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/hep4.1419","article-title":"Mortality related to nonalcoholic fatty liver disease is increasing in the united states","volume":"3","author":"Paik","year":"2019","journal-title":"Hepatol Commun"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/s0016-5085(98)70599-2","article-title":"Steatohepatitis: A tale of two \u201cHits\u201d","volume":"114","author":"Day","year":"1998","journal-title":"Gastroenterology"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2020.02.025","article-title":"Role of oxidative stress in the pathogenesis of nonalcoholic fatty liver disease","volume":"152","author":"Chen","year":"2020","journal-title":"Free Radical Biol Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24001","article-title":"Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis","volume":"52","author":"Tilg","year":"2010","journal-title":"Hepatology"},{"key":"B10","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41423-020-00579-3","article-title":"Immunological mechanisms and therapeutic targets of fatty liver diseases","volume":"18","author":"Wang","year":"2021","journal-title":"Cell Mol Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/nri3738","article-title":"Regional specialization within the intestinal immune system","volume":"14","author":"Mowat","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2015.12.012","article-title":"The multiple-hit pathogenesis of non-alcoholic fatty liver disease (Nafld)","volume":"65","author":"Buzzetti","year":"2016","journal-title":"Metabolism"},{"key":"B13","doi-asserted-by":"publisher","first-page":"66","DOI":"10.3390\/children4080066","article-title":"Gut\u2013liver axis derangement in non-alcoholic fatty liver disease","volume":"4","author":"Poeta","year":"2017","journal-title":"Children"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2630","DOI":"10.1097\/md.0000000000002630","article-title":"Prediction of nonalcoholic fatty liver disease via a novel panel of serum adipokines","volume":"95","author":"Jamali","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(82)80403-4","article-title":"Hepatic steatosis after intestinal bypass\u2013prevention and reversal by metronidazole, irrespective of protein-calorie malnutrition","volume":"82","author":"Drenick","year":"1982","journal-title":"Gastroenterology"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.4067\/s0034-98872021000400570","article-title":"Rol de la microbiota intestinal en El desarrollo del h\u00edgado graso no alcoh\u00f3lico","volume":"149","author":"Tumani","year":"2021","journal-title":"Rev m\u00e9dica Chile"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13376","article-title":"Systematic review: Microbial dysbiosis and nonalcoholic fatty liver disease","volume":"42","author":"Wieland","year":"2015","journal-title":"Alimentary Pharmacol Ther"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1097\/meg.0000000000001541","article-title":"Small intestinal bacterial overgrowth and nonalcoholic fatty liver disease: A systematic review and meta-analysis","volume":"32","author":"Wijarnpreecha","year":"2020","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"B19","article-title":"Intestinal mucosal barrier dysfunction participates in the progress of nonalcoholic fatty liver disease","volume":"8","author":"Mao","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.660179","article-title":"The role of the gut-liver axis in metabolic dysfunction-associated fatty liver disease","volume":"12","author":"Mart\u00edn-Mateos","year":"2021","journal-title":"Front Immunol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22848","article-title":"Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease","volume":"49","author":"Miele","year":"2009","journal-title":"Hepatology"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.5754\/hge12760","article-title":"Expression of intestinal tight junction proteins in patients with non-alcoholic fatty liver disease","volume":"61","author":"Xin","year":"2014","journal-title":"Hepatogastroenterology"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-016-4049-x","article-title":"Innate immunity and inflammation in Nafld\/Nash","volume":"61","author":"Arrese","year":"2016","journal-title":"Dig Dis Sci"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31056","article-title":"Increased liver localization of lipopolysaccharides in human and experimental nafld","volume":"72","author":"Carpino","year":"2020","journal-title":"Hepatology"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.2147\/dmso.S249949","article-title":"Serum lps and Cd163 biomarkers confirming the role of gut dysbiosis in overweight patients with Nash","volume":"13","author":"Hegazy","year":"2020","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20020395","article-title":"Gut-liver axis, gut microbiota, and its modulation in the management of liver diseases: A review of the literature","volume":"20","author":"Milosevic","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The gut-liver axis in liver disease: Pathophysiological basis for therapy","volume":"72","author":"Albillos","year":"2020","journal-title":"J Hepatol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.immuni.2018.12.018","article-title":"The short chain fatty acid butyrate imprints an antimicrobial program in macrophages","volume":"50","author":"Schulthess","year":"2019","journal-title":"Immunity"},{"key":"B29","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/mi.2014.44","article-title":"Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mtor-S6k pathway","volume":"8","author":"Park","year":"2015","journal-title":"Mucosal Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/nu3100858","article-title":"Regulation of inflammation by short chain fatty acids","volume":"3","author":"Vinolo","year":"2011","journal-title":"Nutrients"},{"key":"B31","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3748\/wjg.v23.i1.60","article-title":"Sodium butyrate attenuates high-fat diet-induced steatohepatitis in mice by improving gut microbiota and gastrointestinal barrier","volume":"23","author":"Zhou","year":"2017","journal-title":"World J Gastroenterol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1053\/j.gastro.2020.08.004","article-title":"Efficacy and safety of aldafermin, an engineered Fgf19 analog, in a randomized, double-blind, placebo-controlled trial of patients with nonalcoholic steatohepatitis","volume":"160","author":"Harrison","year":"2021","journal-title":"Gastroenterology"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.92972","article-title":"Intestinal dysbiosis and non-alcoholic fatty liver disease","author":"Auguet","year":"2020","journal-title":"Human Microbiome"},{"key":"B34","article-title":"Dysregulation of bile acids in patients with nafld","volume-title":"Nonalcoholic Fatty Liver Disease - An Update","author":"Zhang","year":"2018"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/8507583","article-title":". Gut microbiota-derived mediators as potential markers in nonalcoholic fatty liver disease","volume":"2019","author":"Aragon\u00e8s","year":"2019","journal-title":"BioMed Res Int"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1055\/s-0042-1748037","article-title":"Intestinal barrier dysfunction in fatty liver disease: Roles of microbiota, mucosal immune system, and bile acids","volume":"42","author":"Gupta","year":"2022","journal-title":"Semin Liver Dis"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/7659509","article-title":"Role of bile acids in dysbiosis and treatment of nonalcoholic fatty liver disease","volume":"2019","author":"Wang","year":"2019","journal-title":"Med Inflamm"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.R024794","article-title":"Bile acid receptors as targets for the treatment of dyslipidemia and cardiovascular disease","volume":"53","author":"Porez","year":"2012","journal-title":"J Lipid Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-010-9202-6","article-title":"Effects of nuclear receptor fxr on the regulation of liver lipid metabolism in patients with non-alcoholic fatty liver disease","volume":"4","author":"Yang","year":"2010","journal-title":"Hepatol Int"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2193-0","article-title":"Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells","volume":"581","author":"Campbell","year":"2020","journal-title":"Nature"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.949033","article-title":"Bile acids in immunity: Bidirectional mediators between the host and the microbiota","volume":"13","author":"Godlewska","year":"2022","journal-title":"Front Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.12740","article-title":"The effects of a Tgr5 agonist and a dipeptidyl peptidase iv inhibitor on dextran sulfate sodium-induced colitis in mice","volume":"30","author":"Sakanaka","year":"2015","journal-title":"J Gastroenterol Hepatol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1155\/2012\/538452","article-title":"The impact of farnesoid X receptor activation on intestinal permeability in inflammatory bowel disease","volume":"26","author":"Stojancevic","year":"2012","journal-title":"Can J Gastroenterol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/s41385-021-00389-4","article-title":"Human gut-associated lymphoid tissues (Galt); diversity, structure, and function","volume":"14","author":"M\u00f6rbe","year":"2021","journal-title":"Mucosal Immunol"},{"key":"B45","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.immuni.2020.02.001","article-title":"Immune profiling of human gut-associated lymphoid tissue identifies a role for isolated lymphoid follicles in priming of region-specific immunity","volume":"52","author":"Fenton","year":"2020","journal-title":"Immunity"},{"key":"B46","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1159\/000518407","article-title":"The role of innate immune cells in nonalcoholic fatty liver disease","volume":"14","author":"Nati","year":"2022","journal-title":"J Innate Immun"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2016.01.025","article-title":"Inflammation in alcoholic and nonalcoholic fatty liver disease: Friend or foe","volume":"150","author":"Gao","year":"2016","journal-title":"Gastroenterology"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00177","article-title":"Role of innate immune response in non-alcoholic fatty liver disease: Metabolic complications and therapeutic tools","volume":"5","author":"Meli","year":"2014","journal-title":"Front Immunol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jaci.2009.05.038","article-title":"Intestinal barrier function: Molecular regulation and disease pathogenesis","volume":"124","author":"Groschwitz","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1038\/ismej.2017.24","article-title":"Faecalibacterium prausnitzii treatment improves hepatic health and reduces adipose tissue inflammation in high-fat fed mice","volume":"11","author":"Munukka","year":"2017","journal-title":"ISME J"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1177\/1756283x16645055","article-title":"Probiotics modify tight-junction proteins in an animal model of nonalcoholic fatty liver disease","volume":"9","author":"Briskey","year":"2016","journal-title":"Therap Adv Gastroenterol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v25.i33.4814","article-title":"Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantation","volume":"25","author":"Nicoletti","year":"2019","journal-title":"World J Gastroenterol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(19)33041-7","article-title":"Obeticholic acid for the treatment of non-alcoholic steatohepatitis: Interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial","volume":"394","author":"Younossi","year":"2019","journal-title":"Lancet"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.068601","article-title":"Paneth cells: Their role in innate immunity and inflammatory disease","volume":"54","author":"Elphick","year":"2005","journal-title":"Gut"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.00587","article-title":"The paneth cell: The curator and defender of the immature small intestine","volume":"11","author":"Lueschow","year":"2020","journal-title":"Front Immunol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"e9302","DOI":"10.15252\/emmm.201809302","article-title":"The role of the microbiome in nafld and Nash","volume":"11","author":"Kolodziejczyk","year":"2019","journal-title":"EMBO Mol Med"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2021.104859","article-title":"Nuciferine prevents hepatic steatosis associated with improving intestinal mucosal integrity, mucus-related microbiota and inhibiting Tlr4\/Myd88\/Nf-Kb pathway in high-fat induced rats","volume":"88","author":"Fan","year":"2022","journal-title":"J Funct Foods"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2016.00498","article-title":"Vitamin d signaling through induction of paneth cell defensins maintains gut microbiota and improves metabolic disorders and hepatic steatosis in animal models","volume":"7","author":"Su","year":"2016","journal-title":"Front Physiol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19103064","article-title":"Roles of gut-derived secretory factors in the pathogenesis of non-alcoholic fatty liver disease and their possible clinical applications","volume":"19","author":"Okubo","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1038\/srep20157","article-title":"Involvement of resistin-like molecule B in the development of methionine-choline deficient diet-induced non-alcoholic steatohepatitis in mice","volume":"6","author":"Okubo","year":"2016","journal-title":"Sci Rep"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1080\/21688370.2021.1879719","article-title":"Role of microbiota and related metabolites in gastrointestinal tract barrier function in nafld","volume":"9","author":"Fernandez-Cantos","year":"2021","journal-title":"Tissue Barriers"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2022.813783","article-title":"Alleviation of hepatic steatosis: Dithizone-related gut microbiome restoration during paneth cell dysfunction","volume":"13","author":"Zhang","year":"2022","journal-title":"Front Microbiol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/nri2707","article-title":"Toll-like receptor signalling in the intestinal epithelium: How bacterial recognition shapes intestinal function","volume":"10","author":"Abreu","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.redox.2017.05.005","article-title":"Hmgb1-rage pathway drives peroxynitrite signaling-induced ibd-like inflammation in murine nonalcoholic fatty liver disease","volume":"13","author":"Chandrashekaran","year":"2017","journal-title":"Redox Biol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-020-03656-y","article-title":"Tlr4 and Cd14 trafficking and its influence on lps-induced pro-inflammatory signaling","volume":"78","author":"Ciesielska","year":"2021","journal-title":"Cell Mol Life Sci"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.4161\/viru.23354","article-title":"Toll-like receptor signaling and regulation of intestinal immunity","volume":"4","author":"Kamdar","year":"2013","journal-title":"Virulence"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1172\/JCI59150","article-title":"Cx3cr1 regulates intestinal macrophage homeostasis, bacterial translocation, and colitogenic Th17 responses in mice","volume":"121","author":"Medina-Contreras","year":"2011","journal-title":"J Clin Invest"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1002\/hep.27982","article-title":"Cx3cr1 is a gatekeeper for intestinal barrier integrity in mice: Limiting steatohepatitis by maintaining intestinal homeostasis","volume":"62","author":"Schneider","year":"2015","journal-title":"Hepatology"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2011.10.016","article-title":"Roles of ppars in nafld: Potential therapeutic targets","volume":"1821","author":"Tailleux","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagrm.2016.03.002","article-title":"Nuclear receptors and nonalcoholic fatty liver disease","volume":"1859","author":"Cave","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/nri912","article-title":"Emerging roles of ppars in inflammation and immunity","volume":"2","author":"Daynes","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1210\/edrv.20.5.0380","article-title":"Peroxisome proliferator-activated receptors: Nuclear control of metabolism","volume":"20","author":"Desvergne","year":"1999","journal-title":"Endocr Rev"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2009.02.004","article-title":"The role of pparalpha in lipid metabolism and obesity: Focusing on the effects of estrogen on pparalpha actions","volume":"60","author":"Yoon","year":"2009","journal-title":"Pharmacol Res"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1038\/nm1044","article-title":"Pgc-1 promotes insulin resistance in liver through ppar-Alpha-Dependent induction of trb-3","volume":"10","author":"Koo","year":"2004","journal-title":"Nat Med"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2003.50307","article-title":"Central role of pparalpha-dependent hepatic lipid turnover in dietary steatohepatitis in mice","volume":"38","author":"Ip","year":"2003","journal-title":"Hepatology"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4419-9072-3_22","article-title":"A paradigm for gene regulation: Inflammation, nf-kappab and ppar","volume":"544","author":"Vanden Berghe","year":"2003","journal-title":"Adv Exp Med Biol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M004045200","article-title":"Induction of ikappabalpha expression as a mechanism contributing to the anti-inflammatory activities of peroxisome proliferator-activated receptor-alpha activators","volume":"275","author":"Delerive","year":"2000","journal-title":"J Biol Chem"},{"key":"B78","doi-asserted-by":"publisher","first-page":"8298","DOI":"10.3390\/ijms22158298","article-title":"Ppars as metabolic sensors and therapeutic targets in liver diseases","volume":"22","author":"Monroy-Ramirez","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0306981100","article-title":"Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome","volume":"100","author":"Tanaka","year":"2003","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00730","article-title":"Peroxisome proliferator-activated receptors: Experimental targeting for the treatment of inflammatory bowel diseases","volume":"11","author":"Decara","year":"2020","journal-title":"Front Pharmacol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.33549\/physiolres.934411","article-title":"Peroxisome proliferator-activated receptor gamma in white and brown adipocyte regulation and differentiation","volume":"69","author":"Wu","year":"2020","journal-title":"Physiol Res"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2020.106565","article-title":"Activation of ppar-\u0393 induces macrophage polarization and reduces neutrophil migration mediated by heme oxygenase 1","volume":"84","author":"Abdalla","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.4292\/wjgpt.v6.i4.137","article-title":"Mesalazine preparations for the treatment of ulcerative colitis: Are all created equal","volume":"6","author":"Ye","year":"2015","journal-title":"World J Gastrointest Pharmacol Ther"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1172\/JCI29881","article-title":"Obesity induces a phenotypic switch in adipose tissue macrophage polarization","volume":"117","author":"Lumeng","year":"2007","journal-title":"J Clin Invest"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1038\/srep44612","article-title":"Effect of modulation of ppar-\u0393 activity on kupffer cells M1\/M2 polarization in the development of non-alcoholic fatty liver disease","volume":"7","author":"Luo","year":"2017","journal-title":"Sci Rep"},{"key":"B86","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1097\/mib.0000000000000955","article-title":"An overview of the innate and adaptive immune system in inflammatory bowel disease","volume":"23","author":"Choy","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20133328","article-title":"The Nlrp3 inflammasome: An overview of mechanisms of activation and regulation","volume":"20","author":"Kelley","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.694833","article-title":"Emerging complexity in Cd4(+)T lineage programming and its implications in colorectal cancer","volume":"12","author":"DiToro","year":"2021","journal-title":"Front Immunol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1007\/s00005-014-0293-y","article-title":"Heterogeneity in the differentiation and function of Cd8+ T cells","volume":"62","author":"Mittr\u00fccker","year":"2014","journal-title":"Archivum Immunologiae Therapiae Experimentalis"},{"key":"B90","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/hep.26267","article-title":"Dendritic cells limit fibroinflammatory injury in nonalcoholic steatohepatitis in mice","volume":"58","author":"Henning","year":"2013","journal-title":"Hepatol (Baltimore Md)"},{"key":"B91","doi-asserted-by":"publisher","first-page":"698","DOI":"10.3760\/cma.j.issn.1007-3418.2019.09.008","article-title":"[Study on the correlation between small intestinal dendritic cells and non-alcoholic fatty liver disease in mice]","volume":"27","author":"Fang","year":"2019","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-012-2073-z","article-title":"Innate immune reactivity of the ileum\u2013liver axis in nonalcoholic steatohepatitis","volume":"57","author":"Tsujimoto","year":"2012","journal-title":"Digestive Dis Sci"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01212","article-title":"Effector T helper cell subsets in inflammatory bowel diseases","volume":"9","author":"Imam","year":"2018","journal-title":"Front Immunol"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1136\/gut.51.3.301","article-title":"T-Bet and mucosal Th1 responses in the gastrointestinal tract","volume":"51","author":"Weigmann","year":"2002","journal-title":"Gut"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1097\/MOG.0000000000000212","article-title":"Role of type 2 immunity in intestinal inflammation","volume":"31","author":"Bamias","year":"2015","journal-title":"Curr Opin Gastroenterol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1016\/j.jaci.2009.03.016","article-title":"Regulation of Th17 cells in the mucosal surfaces","volume":"123","author":"Mucida","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-020-0480-3","article-title":"Immunological distinctions between nonalcoholic steatohepatitis and hepatocellular carcinoma","volume":"52","author":"Koo","year":"2020","journal-title":"Exp Mol Med"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1007\/s00281-022-00917-9","article-title":"Th17 cells in the liver: Balancing autoimmunity and pathogen defense","author":"Taniki","year":"2022","journal-title":"Semin Immunopathol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1007\/978-94-017-9487-9_8","article-title":"The biology and functions of Th22 cells","volume":"841","author":"Jia","year":"2014","journal-title":"Adv Exp Med Biol"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.688066","article-title":"Role of Th22 cells in the pathogenesis of autoimmune diseases","volume":"12","author":"Jiang","year":"2021","journal-title":"Front Immunol"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01139","article-title":"A decade of Th9 cells: Role of Th9 cells in inflammatory bowel disease","volume":"9","author":"Vyas","year":"2018","journal-title":"Front Immunol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2013.00232","article-title":"Peripherally induced tregs \u2013 role in immune homeostasis and autoimmunity","volume":"4","author":"Yadav","year":"2013","journal-title":"Front Immunol"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1586\/eci.10.34","article-title":"Mucosal T cells in gut homeostasis and inflammation","volume":"6","author":"van Wijk","year":"2010","journal-title":"Expert Rev Clin Immunol"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/4735040","article-title":"Gut microbiota modulation on intestinal mucosal adaptive immunity","volume":"2019","author":"Wang","year":"2019","journal-title":"J Immunol Res"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.0366-6999.2012.02.026","article-title":"Intestinal immune barrier integrity in rats with nonalcoholic hepatic steatosis and steatohepatitis","volume":"125","author":"Su","year":"2012","journal-title":"Chin Med J (Engl)"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2015.03.001","article-title":"Regulation of obesity-related insulin resistance with gut anti-inflammatory agents","volume":"21","author":"Luck","year":"2015","journal-title":"Cell Metab"},{"key":"B107","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cellimm.2019.01.005","article-title":"Mesenteric lymph node Cd4+ T lymphocytes migrate to liver and contribute to non-alcoholic fatty liver disease","volume":"337","author":"Su","year":"2019","journal-title":"Cell Immunol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1038\/srep08096","article-title":"Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease","volume":"5","author":"Jiang","year":"2015","journal-title":"Sci Rep"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01582","article-title":"The roles of liver-resident lymphocytes in liver diseases","volume":"10","author":"Wang","year":"2019","journal-title":"Front Immunol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1053\/j.gastro.2017.02.016","article-title":"Gut-specific delivery of T-helper 17 cells reduces obesity and insulin resistance in mice","volume":"152","author":"Hong","year":"2017","journal-title":"Gastroenterology"},{"key":"B111","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.bbrc.2020.12.007","article-title":"Impaired Ccr9\/Ccl25 signalling induced by inefficient dendritic cells contributes to intestinal immune imbalance in nonalcoholic steatohepatitis","volume":"534","author":"Gao","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"key":"B112","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1111\/imr.12916","article-title":"Gut \u0393\u03b4 T cells as guardians, disruptors, and instigators of cancer","volume":"298","author":"Suzuki","year":"2020","journal-title":"Immunol Rev"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjx039","article-title":"Gammadelta T cells in crohn\u2019s disease: A new player in the disease pathogenesis","volume":"11","author":"Catalan-Serra","year":"2017","journal-title":"J Crohn\u2019s Colitis"},{"key":"B114","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1365-2567.2008.02813.x","article-title":"Mechanisms of regulatory T-cell suppression - a diverse arsenal for a moving target","volume":"124","author":"Sojka","year":"2008","journal-title":"Immunology"},{"key":"B115","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/nri.2016.36","article-title":"Development and maintenance of intestinal regulatory T cells","volume":"16","author":"Tanoue","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13159","article-title":"Immunotherapy with oral administration of humanized anti-Cd3 monoclonal antibody: A novel gut-immune system-based therapy for metaflammation and Nash","volume":"193","author":"Ilan","year":"2018","journal-title":"Clin Exp Immunol"},{"key":"B117","doi-asserted-by":"publisher","first-page":"889","DOI":"10.2217\/imt-2016-0049","article-title":"Therapeutic anti-Cd3 monoclonal antibodies: From bench to bedside","volume":"8","author":"Kuhn","year":"2016","journal-title":"Immunotherapy"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0175406","article-title":"Fructo-oligosaccharides and intestinal barrier function in a methionine-Choline-Deficient mouse model of nonalcoholic steatohepatitis","volume":"12","author":"Matsumoto","year":"2017","journal-title":"PloS One"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.14.3254","article-title":"Change of intestinal mucosa barrier function in the progress of non-alcoholic steatohepatitis in rats","volume":"14","author":"Li","year":"2008","journal-title":"World J Gastroenterol"},{"key":"B120","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1007\/s00535-017-1400-8","article-title":"Immunoglobulin a and liver diseases","volume":"53","author":"Inamine","year":"2018","journal-title":"J Gastroenterol"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1038\/nri1784","article-title":"Aberrant homing of mucosal T cells and extra-intestinal manifestations of inflammatory bowel disease","volume":"6","author":"Adams","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"B122","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-7643-8550-7_130","article-title":"Lymphocyte homing and trafficking","volume-title":"Compendium of inflammatory diseases","author":"de Chaisemartin","year":"2016"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.1A1116-463RR","article-title":"Differential T cell homing to colon vs. small intestine is imprinted by local Cd11c+ apcs that determine homing receptors","volume":"102","author":"Dzutsev","year":"2017","journal-title":"J Leukocyte Biol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(02)07374-9","article-title":"Homing of mucosal lymphocytes to the liver in the pathogenesis of hepatic complications of inflammatory bowel disease","volume":"359","author":"Grant","year":"2002","journal-title":"Lancet"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20041035","article-title":"Hepatic endothelial Ccl25 mediates the recruitment of Ccr9+ gut-homing lymphocytes to the liver in primary sclerosing cholangitis","volume":"200","author":"Eksteen","year":"2004","journal-title":"J Exp Med"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.13183","article-title":"Gut-derived lymphocyte recruitment to liver and induce liver injury in non-alcoholic fatty liver disease mouse model.","volume":"31","author":"Hu","year":"2016","journal-title":"J Gastroenterol Hepatol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.20517\/2394-5079.2021.46","article-title":"Role of Cd4<Sup>+ <\/Sup>T-cells in the pathology of non-alcoholic fatty liver disease and related diseases","volume":"7","author":"Seike","year":"2021","journal-title":"Hepatoma Res"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.09.033","article-title":"Role of cc chemokine receptor 9 in the progression of murine and human non-alcoholic steatohepatitis","volume":"74","author":"Morikawa","year":"2021","journal-title":"J Hepatol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.13183","article-title":"Gut-derived lymphocyte recruitment to liver and induce liver injury in non-alcoholic fatty liver disease mouse model","volume":"31","author":"Hu","year":"2016","journal-title":"J Gastroenterol Hepatol"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.02.001","article-title":"B (7)-integrin and madcam-1 play opposing roles during the development of non-alcoholic steatohepatitis","volume":"66","author":"Drescher","year":"2017","journal-title":"J Hepatol"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.05.047","article-title":"Blocking integrin# \u00b1 4\u00b27-mediated Cd4 T cell recruitment to the intestine and liver protects mice from Western diet-induced non-alcoholic steatohepatitis","author":"Rai","year":"2020","journal-title":"J Hepatol"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2020.597648","article-title":"Chronic inflammation in non-alcoholic steatohepatitis: Molecular mechanisms and therapeutic strategies","volume":"11","author":"Luci","year":"2020","journal-title":"Front Endocrinol"},{"key":"B133","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41575-019-0210-2","article-title":"Adaptive immunity: An emerging player in the progression of nafld","volume":"17","author":"Sutti","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/362847","article-title":"Role of toll-like receptors and their downstream molecules in the development of nonalcoholic fatty liver disease","volume":"2010","author":"Miura","year":"2010","journal-title":"Gastroenterol Res Pract"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1016\/0168-8278(95)80433-1","article-title":"Human kupffer cells secrete il-10 in response to lipopolysaccharide (Lps) challenge","volume":"22","author":"Knolle","year":"1995","journal-title":"J Hepatol"},{"key":"B136","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.livres.2020.01.002","article-title":"Functional roles of Ccl5\/Rantes in liver disease","volume":"4","author":"Chen","year":"2020","journal-title":"Liver Res"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1002\/cphy.c120026","article-title":"Kupffer cells in the liver","volume":"3","author":"Dixon","year":"2013","journal-title":"Compr Physiol"},{"key":"B138","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.180.7.5067","article-title":"High mobility group box 1 protein binding to lipopolysaccharide facilitates transfer of lipopolysaccharide to Cd14 and enhances lipopolysaccharide-mediated tnf-alpha production in human monocytes","volume":"180","author":"Youn","year":"2008","journal-title":"J Immunol"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v20.i23.7381","article-title":"Role of gut microbiota and toll-like receptors in nonalcoholic fatty liver disease","volume":"20","author":"Miura","year":"2014","journal-title":"World J Gastroenterol"},{"key":"B140","article-title":"Hepatic steatosis causes induction of the chemokine rantes in the absence of significant hepatic inflammation","volume":"3","author":"Kirovski","year":"2010","journal-title":"Int J Clin Exp Pathol"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1172\/JCI41732","article-title":"Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice","volume":"120","author":"Berres","year":"2010","journal-title":"J Clin Invest"},{"key":"B142","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-300304","article-title":"Pharmacological inhibition of the chemokine Ccl2 (Mcp-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury","volume":"61","author":"Baeck","year":"2012","journal-title":"Gut"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.2337\/db09-0016","article-title":"Depletion of liver kupffer cells prevents the development of diet-induced hepatic steatosis and insulin resistance","volume":"59","author":"Huang","year":"2010","journal-title":"Diabetes"},{"key":"B144","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1038\/nrgastro.2015.200","article-title":"Immunology in the liver\u2013from homeostasis to disease","volume":"13","author":"Heymann","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.655697","article-title":"Hepatocellular carcinoma immune landscape and the potential of immunotherapies","volume":"12","author":"Giraud","year":"2021","journal-title":"Front Immunol"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.01969","article-title":"Type ii nkt cells: An elusive population with immunoregulatory properties","volume":"9","author":"Singh","year":"2018","journal-title":"Front Immunol"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0080949","article-title":"Mice lacking natural killer T cells are more susceptible to metabolic alterations following high fat diet feeding","volume":"9","author":"Martin-Murphy","year":"2014","journal-title":"PloS One"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1002\/oby.20823","article-title":"Systemic nk cell ablation attenuates intra-abdominal adipose tissue macrophage infiltration in murine obesity","volume":"22","author":"O\u2019Rourke","year":"2014","journal-title":"Obes (Silver Spring)"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.751802","article-title":"Role of neutrophils in the pathogenesis of nonalcoholic steatohepatitis","volume":"12","author":"Hwang","year":"2021","journal-title":"Front Endocrinol"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0052411","article-title":"Neutrophil-derived myeloperoxidase aggravates non-alcoholic steatohepatitis in low-density lipoprotein receptor-deficient mice","volume":"7","author":"Rensen","year":"2012","journal-title":"PloS One"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2885","article-title":"Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase","volume":"18","author":"Talukdar","year":"2012","journal-title":"Nat Med"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2009.080999","article-title":"Increased hepatic myeloperoxidase activity in obese subjects with nonalcoholic steatohepatitis","volume":"175","author":"Rensen","year":"2009","journal-title":"Am J Pathol"},{"key":"B153","doi-asserted-by":"publisher","first-page":"G89","DOI":"10.1152\/ajpgi.00333.2016","article-title":"The emerging role of mast cells in liver disease","volume":"313","author":"Jarido","year":"2017","journal-title":"Am J Physiology-Gastrointestinal Liver Physiol"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1016\/j.humpath.2018.11.029","article-title":"Hepatic mast cell concentration directly correlates to stage of fibrosis in Nash","volume":"86","author":"Lombardo","year":"2019","journal-title":"Hum Pathol"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1136\/gut.52.2.307","article-title":"Dendritic cells and immune regulation in the liver","volume":"52","author":"Lau","year":"2003","journal-title":"Gut"},{"key":"B156","doi-asserted-by":"publisher","DOI":"10.1002\/hep.22306","article-title":"Toll-like receptors and adaptor molecules in liver disease: Update","volume":"48","author":"Seki","year":"2008","journal-title":"Hepatology"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.760860","article-title":"Emerging roles of T cells in the pathogenesis of nonalcoholic steatohepatitis and hepatocellular carcinoma","volume":"12","author":"Hirsova","year":"2021","journal-title":"Front Endocrinol"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.01.008","article-title":"Murine Cd103(+) dendritic cells protect against steatosis progression towards steatohepatitis","volume":"66","author":"Heier","year":"2017","journal-title":"J Hepatol"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01344-3","article-title":"Xcr1(+) type 1 conventional dendritic cells drive liver pathology in non-alcoholic steatohepatitis","volume":"27","author":"Deczkowska","year":"2021","journal-title":"Nat Med"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v26.i20.2559","article-title":"Role of \u0393\u03b4t cells in liver diseases and its relationship with intestinal microbiota","volume":"26","author":"Zhou","year":"2020","journal-title":"World J Gastroenterol"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222212190","article-title":"T Cell subsets and natural killer cells in the pathogenesis of nonalcoholic fatty liver disease","volume":"22","author":"Gebru","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31755","article-title":"Microbiota-driven activation of intrahepatic b cells aggravates Nash through innate and adaptive signaling","volume":"74","author":"Barrow","year":"2021","journal-title":"Hepatology"},{"key":"B163","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","article-title":"Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis","volume":"149","author":"Vilar-Gomez","year":"2015","journal-title":"Gastroenterology"},{"key":"B164","doi-asserted-by":"publisher","first-page":"4305","DOI":"10.3390\/ijms23084305","article-title":"Ppar-targeted therapies in the treatment of non-alcoholic fatty liver disease in diabetic patients","volume":"23","author":"Lange","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.793203","article-title":"Efficacy of off-label therapy for non-alcoholic fatty liver disease in improving non-invasive and invasive biomarkers: A systematic review and network meta-analysis of randomized controlled trials","volume":"9","author":"Luo","year":"2022","journal-title":"Front Med"},{"key":"B166","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3390\/diseases6040086","article-title":"The role of vitamin e in the treatment of nafld","volume":"6","author":"Perumpail","year":"2018","journal-title":"Diseases"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2028395","article-title":"A placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis","volume":"384","author":"Newsome","year":"2021","journal-title":"N Engl J Med"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8936865","article-title":"Glp-1 receptor agonist effects on lipid and liver profiles in patients with nonalcoholic fatty liver disease: Systematic review and meta-analysis","volume":"2021","author":"Rezaei","year":"2021","journal-title":"Can J Gastroenterol Hepatol"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.729950","article-title":"Probiotics-based treatment as an integral approach for alcohol use disorder in alcoholic liver disease","volume":"12","author":"Fuenzalida","year":"2021","journal-title":"Front Pharmacol"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.1080\/17474124.2022.2016391","article-title":"Effects of probiotics on nonalcoholic fatty liver disease: A systematic review and meta-analysis","volume":"15","author":"Yang","year":"2021","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1016\/j.eng.2020.01.017","article-title":"An update on the efficacy and functionality of probiotics for the treatment of non-alcoholic fatty liver disease","volume":"7","author":"Yao","year":"2021","journal-title":"Engineering"},{"key":"B172","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.mce.2012.05.004","article-title":"Fxr signaling in the enterohepatic system","volume":"368","author":"Matsubara","year":"2013","journal-title":"Mol Cell Endocrinol"},{"key":"B173","doi-asserted-by":"publisher","first-page":"e4529","DOI":"10.1097\/md.0000000000004529","article-title":"Comparative efficacy of interventions on nonalcoholic fatty liver disease (Nafld): A prisma-compliant systematic review and network meta-analysis","volume":"95","author":"Sawangjit","year":"2016","journal-title":"Med (Baltimore)"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109609","article-title":"Role of farnesoid X receptor in hepatic steatosis in nonalcoholic fatty liver disease","volume":"121","author":"Xi","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(14)61933-4","article-title":"Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (Flint): A multicentre, randomised, placebo-controlled trial","volume":"385","author":"Neuschwander-Tetri","year":"2015","journal-title":"Lancet"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2007.04.019","article-title":"Toll-like receptor-4 signaling and kupffer cells play pivotal roles in the pathogenesis of non-alcoholic steatohepatitis","volume":"47","author":"Rivera","year":"2007","journal-title":"J Hepatol"},{"key":"B177","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00563","article-title":"Targeting myeloid-derived cells: New frontiers in the treatment of non-alcoholic and alcoholic liver disease","volume":"10","author":"Vonghia","year":"2019","journal-title":"Front Immunol"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-017-1415-1","article-title":"Current and future pharmacological therapies for Nafld\/Nash","volume":"53","author":"Sumida","year":"2018","journal-title":"J Gastroenterol"},{"key":"B179","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/S0168-8278(18)30425-2","article-title":"Jkb-121 in patients with nonalcoholic steatohepatitis: A phase 2 double blind randomized placebo control study","volume":"68","author":"Diehl","year":"2018","journal-title":"J Hepatol"},{"key":"B180","doi-asserted-by":"publisher","first-page":"3997","DOI":"10.2147\/DDDT.S315724","article-title":"Non-alcoholic steatohepatitis (Nash) - a review of a crowded clinical landscape, driven by a complex disease","volume":"15","author":"Fraile","year":"2021","journal-title":"Drug Des Devel Ther"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29514","article-title":"The Ask1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial","volume":"67","author":"Loomba","year":"2018","journal-title":"Hepatology"},{"key":"B182","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1053\/j.gastro.2016.01.038","article-title":"Elafibranor, an agonist of the peroxisome proliferator-activated receptor-a and -\u0394, induces resolution of nonalcoholic steatohepatitis without fibrosis worsening","volume":"150","author":"Ratziu","year":"2016","journal-title":"Gastroenterology"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2036205","article-title":"A randomized, controlled trial of the pan-ppar agonist lanifibranor in Nash","volume":"385","author":"Francque","year":"2021","journal-title":"New Engl J Med"},{"key":"B184","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29477","article-title":"A randomized, placebo-controlled trial of cenicriviroc for treatment of nonalcoholic steatohepatitis with fibrosis","volume":"67","author":"Friedman","year":"2018","journal-title":"Hepatology"},{"key":"B185","doi-asserted-by":"publisher","first-page":"40","DOI":"10.14218\/jcth.2020.00055","article-title":"Drugs for non-alcoholic steatohepatitis (Nash): Quest for the holy grail","volume":"9","author":"Sharma","year":"2021","journal-title":"J Clin Transl Hepatol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.954869\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T10:30:33Z","timestamp":1665397833000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.954869\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,10]]},"references-count":185,"alternative-id":["10.3389\/fimmu.2022.954869"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.954869","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,10]]},"article-number":"954869"}}